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Produce Fatal Liver and Lung
Damage in Mice"
It is EHPs stated editorial policy to serve
as a forum for discussion ofissues ofenvi-
ronmental health, encouraging the expres-
sion of scientific opinion and fostering
healthy scientific debate. Your editorial
policy states that "all scientific articles are
subject to rigorous peer review. The prima-
ry criteria are environmental significance
and scientific quality." Based on these cri-
teria, it appears that the journal has failed
to hold the paper ofLieberman et al. (1) to
these standards. This paper is a blatant and
deliberate misdirection of the reader, pro-
viding misinterpretation of a poorly
designed study that is not up to the stan-
dards ofmodern toxicology or EHP.
Lieberman et al. (1) indicate that they
distilled breast implant gel at 180°C at
reduced pressure for 24 hr and imply that
this material represents what would leak
from implants. It is well known that silicone
polymers can thermally depolymerize to
form cyclic siloxanes under the authors' dis-
tillation conditions (2), but this does not
represent "real life" conditions. Lieberman et
al. (1) administered this distillate to mice by
intraperitoneal (ip) injection at doses up to
35,000 mg/kg-surely an unacceptablyhigh
dose that would cause direct irritation. It is
therefore no surprise that the identified ip
median lethal dose (LD 0) was 28,000
mg/kg and that lung and iver lesions were
noted. Perhaps the animal care committee
should have requested a revision ofthe test-
ing protocol before the study was initiated.
Lieberman et al. (1) reported that one ofthe
individual components of the distillate,
identified as CS-4 based on an ip LD50 of
6,000-7,000 mg/kg, is equivalent in toxicity
to oral exposures to carbon tetrachloride;
they characterized the distillate and individ-
ual distillate materials as highly toxic. For
regulatory purposes, any material with an
LD50 greater than 2,000 mg/kg (3) or 5,000
mg/kg (4-9) is considered to be the highest
dose necessary to test. Materials with LD50
values greater than these dose levels are con-
sidered to bevirtually nontoxic.
Ifthis misinterpretation oftoxicity data
were to remain quietly in the annals of
EHP, it would be merely a problem ofedi-
torial carelessness. However, this paper has
been picked up by several of the news ser-
vices (e.g., Reuters, BBC), with online and
print mediadeclaring "Silicones Kill Mice!"
and no longer noting that the dose and
dose route are responsible for the lethality,
not the inherent toxicity ofthe material. By
publishing this paper, EHP has become a
source for junk science reporters. The fact
that the NIEHS is a well-respected scientif-
ic body only adds more credence to this ill-
conceived and misinterpreted study.
I implore you be more attentive to the
content ofthe articles published in EHP. It
weakens the reputation of the NIEHS,
feeds the junk science machine, and dimin-
ishes the credibility of all toxicologists
when articles such as this are given space in
a peer-reviewed scientific journal.
Betsy D. Carlton
Chemicals Toxicology
Rhodia Inc.
Raleigh, North Carolina
REFERENCES AND NoTEs
1. Lieberman MW, Lykissa ED, Barrios R, Ou CN, Kala
G, Kala SV. Cyclosiloxanes produce fatal liver and
lung damage in mice. Environ Health Perspect
107:161-165(1999).
2. Noll CS. Chemistry and Technology of Silicones.
NewYork:Academic Press, 1968.
3. OECD. Acute Oral Toxicity. Guideline 401. Paris:
Organisation for Economic Co-operation and
Development, 1987.
4. Consumer Product Safety Commission. Hazardous
Substances and Articles; Administration and
Enforcement Regulations. 16 CFR § 1500(1997)
5. FDA. Toxicological Principles for the Safety
Assessment of Direct Food Additives and Color
Additives Used in Food. Washington, DC:Food and
Drug Administration, 1982.
6. FDA. Toxicological Principles for the Safety
Assessment of Direct Food Additives and Color
Additives Used in Food. Redbook Draft. Washington,
DC:Food and Drug Administration, 1992.
7. Environmental Protection Agency. State Registration
of Pesticide Products. 40 CFR 5162.10(1997).
8. U.S. Environmental Protection Agency. Health
Effects Testing Guidelines. 40 CFR § 798(1997)
9. Japanese MAFF. Acute Oral ToxicityTest. 59 NohSan
#4200. Tokyo:Japanese Ministry of Agriculture,
Forestry and Fisheries, 1985.
In the February issue ofEHP, Lieberman et
al. (1) reported that the intraperitoneal (ip)
injection ofeither cyclosiloxanes (CSs) from
silicone breast implant distillate or CS-D4,
a component of breast implant distillate,
was lethal and caused liver and lung damage
and increased hydroxyl radical formation.
This paper is flawed and contains a number
ofscientific issues that need to be addressed.
Lieberman et al. (1) reported that a dis-
tillate from an explanted breast implant
contains anywhere from 2 to 60%
cyclosiloxanes, with CS-D4 being present at
the highest concentration. It is well known
that destructive distillation of a siloxane
polymer or gel at high temperature under
vacuum "cracks" the polymer causing,
under these destructive conditions, the for-
mation of large amounts ofcyclosiloxanes
(2). There is no doubt that the low molecu-
lar weight cyclosiloxanes collected by
Lieberman et al. (1) were created during the
distillation by a "cracking" process. The
conditions required to crack a polymer do
not exist in the human body. Our own
analysis of an intact silicone breast implant
shows that CS-D4 levels rarely, if ever,
exceed approxmately 700 ppm (i.e., 700
pg/g). Migration ofCS-D4 from an implant
occurs at a rate of about 0.58 pg/day (3)
which, for a 60-kg women, equates to a
0.010 pg/kg/dayexposure to CS-D4.
Lieberman et al. (1) reported that after
a single subcutaneous injection in mice of
250 mg (or about 10 g/kg body weight) of
breast implant distillate, the cyclosiloxanes
are widely distributed to many organs and
can be detected as much as 1 year following
a single injection. In their original paper
(4), many of the values reported for tissue
concentrations ofcyclosiloxanes at 9 weeks
and later appeared to be at or below the
limit of detection of their analytical
methodology and were well below what
would be considered the limit ofquantita-
tion, making some of their conclusions
misleading. In our own studies (5-2) using
14C-CS-D4 administration to rats by vari-
ous routes ofexposure, we also showed that
CS-D4 was uniformly distributed to tis-
sues, but with an elimination half-life of
parent and metabolites of 50-200 hr,
depending on the tissue, and < 0.0078% of
the radioactivity left in tissues at 6 weeks
postexposure. These data indicate that it is
unlikely that CS-D4 would be found in tis-
sues 1 year afteradministration.
As for the acute toxicity effects reported
by Lieberman et al. (1), many ofthe report-
ed findings oppose the conventional wis-
dom oftoxicology. Administration ofup to
1 mL ofa substance into the peritoneal cav-
ity ofa 25-30-g mouse (which is equivalent
to 2.4 L injected into the abdominal cavity
of a human) basically represents the maxi-
mum dose that can be administered to a
mouse and far exceeds the dose ofCSs that
could be encountered byhumans under any
condition, including women with breast
implants. The LD50 values of-28 g/kg and
6-7 g/kg reported by Lieberman et al. (1)
for the distillate and CS-D4, respectively,
were used to indicate extreme toxicity,
which is absurd. Credible references in toxi-
cology (8,9) would consider compounds
with acute LD50 values of 5-15 g/kg to be
practically nontoxic, whereas compounds
with LD50 values of > 15 g/kg are consid-
ered relatively harmless. Based on the data
presented by Lieberman et al. (1) and using
these widely accepted criteria, one should
interpret that CS-D4 is practically nontoxic
and the inappropriately prepared breast
implant distillate is relatively harmless.
Lieberman et al. (1) further suggest that by
comparing ip LD50 values to the oral LD50
values of carbon tetrachloride and
trichloroethylene, "the value for CS-D4
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